Aytu BioScience, Inc. (NASDAQ: AYTU) stock slipped in the after-hours market session on Friday as it revealed, due to surging demand, the underwriter has agreed
Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical corporation focusing on the marketing of new drugs targeting critical medical needs, and Neos Therapeutics, Inc. (NASDAQ:
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.